Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Timing of a Tailored Physical Activity Program During Chemotherapeutic Cancer Treatment to Reduce Long-term Cardiovascular Morbidity

NCT01642680 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT01642680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01642680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Timing of a Tailored Physical Activity Program During Chemotherapeutic Cancer Treatment to Reduce Long-term Cardiovascular Morbidity
Lead sponsor
University Medical Center Groningen
Phase
Not applicable
Overall status
Completed
Start date
January 24, 2013
Completion date
October 22, 2020
Enrollment
266 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular risk factors, fatigue, metabolic syndrome, vascular disorders